The synthesis of new 2,3,5,6-aryl substituted tetrahydro-2H-pyrazolo[3,4-d]-thiazoles 4a-j as potential biologically active compounds by the cyclocondensation of phenyl hydrazine with new 5-arylidene derivatives 2a-j of 2,3-disubstituted-1,3-thiazolidin-4-ones 1a-e is reported.
Introduction
Small ring heterocycles containing nitrogen, sulfur and oxygen have been under investigation for a long time because of their important medicinal properties. Among these type of molecules, 4-thiazolidinones have been shown to have various important biological activities such as antibacterial, antifungal, antiviral, diuretic, antituberculostatic, anti-HIV, antihistaminic, anticancer, anticonvulsant, antiinflammatory and analgesic properties [1] [2] [3] [4] [5] .
We have already reported some of our work on the synthesis, transformations and some biological properties of various 4-thiazolidinones [6] [7] [8] [9] . Some of these compounds were screened for their antibacterial and antituberculostatic activities, and it has been found that some of them have moderate to good biological properties [8] . The biological significance of this class of compounds impelled us to continue working on the synthesis of new thiazolidine derivatives. In this study we report the synthesis of some new tetrahydro-2H-pyrazolo [3,4-d] thiazole derivatives starting from various 4-thiazolidinones.
Results and Discussion
The target compounds were prepared starting from 4-thiazolidinone derivatives. In the first step, 4-thiazolidinones 1a-e were synthesized by the Katti carbodiimide (DCC) mediated one-pot threecomponent condensation reaction of an aromatic amine, an aldehyde and a mercaptoacetic acid [10] (Scheme 1). Then compounds 1a-e were reacted with 4-chlorobenzaldehyde and 4-dimethylaminobenzaldehyde in the presence of sodium ethoxide to afford the new 5-benzylidene derivatives 2a-j (Scheme 2). Next, compounds 2a-j condensed with phenyl hydrazine in glacial acetic acid in the presence of sodium acetate to give products 4a-j (Scheme 2). In a typical reaction, 5-benzylidene derivatives, sodium acetate and phenyl hydrazine were refluxed for 7-8 h in glacial acetic acid. The crude reaction mixture was filtered hot to remove any insoluble material, and cooled. Water was added to the resulting mixture which was boiled for a few minutes. Finally, the mixture was cooled to afford the crude product which was then purified by column chromatography using the appropriate solvent system. Compounds 4a-j are presumably formed by way of the phenyl hydrazones 3, followed by cyclization and proton transfer.
The structures of the new compounds were assigned on the basis of their analytical and spectral data. Compounds 1a-e display in their 1 H-NMR spectra, in addition to other signals, doublets at δ 3.81-3.99 ppm due to the H A and H B system. In the benzylidene derivatives 2a-j, this AB system was absent, confirming that condensation had been taken place. Regarding compounds 4a-j, their 1 H-NMR spectra showed two doublets at δ 5.79 -5.82 ppm due to a proton on 3a-CH and at 4.52 -4.58 ppm, due to a proton on 3-CH, respectively. These signals demonstrate that the cyclization step had occurred.
Characteristic C=O bands appeared in the 1702-1682 cm -1 region in the FT-IR spectra of the thiazolidinones 1a-e and benzylidene derivatives 2 a-j. In the FT-IR spectra of compounds 4a-j, the amide carbonyl band was absent, which clearly confirmed that a cyclocondensation with phenyl hydrazine had been taken place. Besides, the C=N bands of 4a-j were observed in the 1596-1602 cm Our results have shown that the sequential condensation of phenyl hydrazine and compounds 2a-f containing carbonyl functionalities is a useful reaction for the construction of novel heterocycles of possible pharmacological interest.
Experimental
General NMR spectra were recorded on a 400 MHz Bruker Digital FT-NMR 'Avance 400' spectrometer. Chemical shifts (δ) are on parts per million (ppm), with CDCl 3 as solvent and relative to tetramethylsilane (TMS) as the internal reference. FT-IR spectra were recorded on Perkin Elmer FT-IR spectrometer (KBr pellets). GC-EIMS spectra were measured on a Varian SAT2100T mit GC3900 spectrometer using ionization by FAB. Melting points were measured on a Gallenkamp melting point apparatus. Silica gel 60 (Merck) was used for column separations. TLC was conducted on standard conversion aluminium sheets pre-coated with a 0.2 mm layer of silica gel. Elemental analyses were measured with a Thermo Flash Flash EA 1112 Series apparatus.
General procedure for the synthesis of 4-thiazolidinones 1a-e
p-Substituted aniline (1 mmol) and 3,4,5-trimethoxybenzaldehyde (2 mmol) were stirred in THF at an ice-bath for 5 min, followed by addition of mercaptoacetic acid (3 mmol). After 5 min DCC (1.2 mmol) was added to the reaction mixture at 0°C and the reaction mixture stirred for additional 1-3 hours at room temperature. Formed DCU was removed by filtration, filtrate was concentrated to dryness under reduced pressure and the residue was taken up with ethyl acetate. The organic layer was washed with 5 % aq. citric acid, water, 5 % aq. sodium hydrogen carbonate and then with brine. The organic layer was dried over sodium sulfate and the solvent removed under vacuum to give the crude product, which was purified by recrystallization from 2:1 petroleum ether-diethyl ether. 
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General procedure for the preparation of 5-arylidine-4-thiazolidinones 2a-j
A solution of 1a-e (1 mmol) and 4-chlorobenzaldehyde (1 mmol) or 4-dimethylaminoaniline (1 mmol) in dry benzene (25 mL) was refluxed for about 10-12 h, in the presence of sodium ethoxide (1 mmol), cooled, poured into ice cold water and then acidified with glacial acetic acid. The benzene layer was separated, dried over CaCl 2 and evaporated in vacuo to give crude product that was purified by recrystallization.
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General method for tetrahydro-2H-pyrazolo[3,4-d]thiazoles 4a-j
The respective benzylidene derivative, 2a-j (1 mmol) in glacial acetic acid (10 mL), sodium acetate (1 g) and phenyl hydrazine (1 mL) were heated for 7 h. The mixture was filtered hot to remove any insoluble material, cooled, and then water was added and boiled for few minutes, then it was cooled to afford the crude product which was purified by column chromatography from n-hexane-ethyl acetate (2:1). 
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